NNAL Clearance in Hair and Urine

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2009 by University of Nebraska.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
Information provided by:
University of Nebraska
ClinicalTrials.gov Identifier:
NCT00863824
First received: March 17, 2009
Last updated: NA
Last verified: March 2009
History: No changes posted
  Purpose

The purpose of the study is to investigate how long it takes for NNAL and cotinine, both specific markers of second hand tobacco smoke exposure to clear the human body.


Condition
Lung Cancer

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Elimination of NNAL and Cotinine From Hair and Urine

Resource links provided by NLM:


Further study details as provided by University of Nebraska:

Estimated Enrollment: 40
Study Start Date: July 2009
Estimated Study Completion Date: June 2010
Estimated Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   19 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Healthy Caucasians and African Americans who are ready to quit smoking.

Criteria

Inclusion Criteria:

  • Healthy caucasians and african americans 19 years of agae or above, how are ready to quit smoking

Exclusion Criteria:

  • Anyone who is not a caucasian or an african-american, below 19 years of age, and is currently taken prescription medication.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00863824

Contacts
Contact: Chandran Achuatn, Ph.D. 402.559.8599 cachutan@unmc.edu

Locations
United States, Nebraska
University of Nebraska Medical Center Not yet recruiting
Omaha, Nebraska, United States, 68198
Sponsors and Collaborators
University of Nebraska
  More Information

No publications provided

Responsible Party: Gail Paulsen, UNMC
ClinicalTrials.gov Identifier: NCT00863824     History of Changes
Other Study ID Numbers: 121-09-EP
Study First Received: March 17, 2009
Last Updated: March 17, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by University of Nebraska:
NNAL
Cotinine
Second hand smoke
NNAL is a known lung carcinogen. So, we are studying an agent that can potentially cause lung cancer.

Additional relevant MeSH terms:
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on July 28, 2014